Rate My Professor Adam Pomerleau

Pomerleau's scholarly output centers on clinical toxicology research pertinent to New Zealand contexts, including poisoning surveillance, treatment protocols, and harm reduction strategies. Notable publications from his University profile include: Yuen, W. Y. R., Pomerleau, A. C., & Liang, J. (2025) 'Acute parenteral poisoning from calcium copper edetate' in Clinical Toxicology; Chiew, A. L. et al. (2025) 'Paracetamol (acetaminophen) poisoning: Consensus definitions of poisoning types and outcomes' in Clinical Toxicology; Kumpula, E.-K. et al. (2024) 'Naloxone use by Aotearoa New Zealand emergency medical services, 2017-2021' in Emergency Medicine Australasia; Kumpula, E.-K. et al. (2023) 'Naloxone use by New Zealand ambulance services in 2017–2021' in Toxicology Communications; and Crossin, R. et al. (2023) 'The New Zealand drug harms ranking study: A multi-criteria decision analysis' in Journal of Psychopharmacology. Additional contributions encompass co-authorship on the 'Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand' (Chiew et al., Medical Journal of Australia, 2020) and analyses of toxicologist consultations and therapeutic errors via the National Poisons Centre. As Editor-in-Chief of TOXINZ, New Zealand's clinical toxicology database, and through committee involvements such as the Medicines Adverse Reactions Committee, he influences national standards in poison management. Pomerleau was promoted to Research Associate Professor effective 1 February 2023.